← Back to Search

N/A

EC with nicotine for Long QT Syndrome

N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in qtc 5 minutes before and 5 minutes after cigarette use
Awards & highlights

Study Summary

This trial looked at the effect of smoking an e-cigarette or a tobacco cigarette on heart function.

Eligible Conditions
  • Long QT Syndrome
  • Sudden Cardiac Death

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in tpe 5 minutes before and 5 minutes after cigarette use
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in tpe 5 minutes before and 5 minutes after cigarette use for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tpe
Tpe/QT
Tpe/QTc
Secondary outcome measures
QT
QTc

Trial Design

3Treatment groups
Experimental Treatment
Group I: Non-userExperimental Treatment3 Interventions
Non- users will use, in a randomized, crossover fashion with a 4 week washout, an 1) EC with nicotine, 2) EC without nicotine, and 3) an empty EC (control)
Group II: Chronic TC smokerExperimental Treatment3 Interventions
Chronic TC smokers will use, in a randomized, crossover fashion with a 4 week washout, a 1) TC with nicotine (own brand), 2) research TC with very low level nicotine, and 3) a straw (control)
Group III: Chronic EC userExperimental Treatment3 Interventions
Chronic EC users will use, in a randomized, crossover fashion with a 4 week washout, an 1) EC with nicotine, 2) EC without nicotine, and 3) an empty EC (control)

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,276,741 Total Patients Enrolled
Tobacco Related Disease Research ProgramOTHER
25 Previous Clinical Trials
20,508 Total Patients Enrolled

Media Library

EC with nicotine (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT03916341 — N/A
Long QT Syndrome Research Study Groups: Non-user, Chronic EC user, Chronic TC smoker
Long QT Syndrome Clinical Trial 2023: EC with nicotine Highlights & Side Effects. Trial Name: NCT03916341 — N/A
EC with nicotine (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03916341 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age of 60 a cutoff for eligibility in this medical experiment?

"To be considered for this trial, applicants must meet the age requirements of 21-45. For those who do not fit within these parameters, there are 23 separate trials available to minors and 77 studies available to seniors."

Answered by AI

What is the scope of participation in this clinical trial?

"Yes, according to clinicaltrials.gov this trial is currently recruiting participants. It was initially posted on October 1st 2019 and the most recent update occurred on September 6th 2022. Currently 145 individuals are needed from a single site for enrollment into the study."

Answered by AI

Is there a possibility to participate in this experiment?

"The research team is seeking 145 volunteers aged 21 to 45 with a history of death. Additionally, the participants must adhere to other criteria such as being non-smokers or having chronic tobacco and electronic cigarette (e-cig) usage habits."

Answered by AI

Is this clinical experiment still recruiting participants?

"Indeed, the latest information on clinicaltrials.gov attests that this research is searching for patients now. This trial first appeared online on October 1st 2019 and was recently refreshed on September 6th 2022. A total of 145 people are desired at one location to partake in this study."

Answered by AI

Who else is applying?

What site did they apply to?
UCaliforniaLA
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Smoking and Ventricular Repolarization
Holly R Middlekauff 2019. "Smoking and Ventricular Repolarization". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03916341.
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top